Data showed that both tumor progress (Fig. 2i and Supplementary Fig 5) and hepatic metastasis of colorectal tumor (Fig. 2j) were dramatically decreased in CCL5−/− mice treated with anti-PD-1 Ab compared with anti-PD-1-Ab-treated CCL5+/+ mice. This evidence concerns the gene CCL5 and colorectal neoplasm.